Abstract
Many effective strategies have been developed in order to inhibit the hydrodechlorination in the selective hydrogenation of chloronitrobenzenes to chloroanilines which are important intermediates in the chemistry and industry of dyes, herbicides, pesticides and medicines. However, hydrogenolysis of the carbon-halogen bond as a defect of the hydrogenation process could not be avoided completely over the metal catalysts reported previously, especially at complete conversion of the substrates. Recently we overcame this problem by the invention of nanocomposite catalysts composed of noble metal nanoclusters and inorganic semiconductor nanoparticles. Over these nanocomposite catalysts, the hydrodechlorination of ortho-chloroaniline was completely suppressed even at 100% conversion of ortho-chloronitrobenzene. In this review, we deal with the great efforts and remarkable contributions of different authors during the long exploration for the solutions of this hard obstacle. Stress is placed on supported metal catalysts and polymer-protected metal nanoclusters or colloid catalysts.
Keywords: hydrogenation, bromonitrobenzenes (BNB), Bimetallic Catalysts, colloids, Metal Complexes
Current Organic Chemistry
Title: Selective Hydrogenation of Aromatic Chloronitro Compounds
Volume: 11 Issue: 3
Author(s): Xiaodong Wang, Minghui Liang, Junling Zhang and Yuan Wang
Affiliation:
Keywords: hydrogenation, bromonitrobenzenes (BNB), Bimetallic Catalysts, colloids, Metal Complexes
Abstract: Many effective strategies have been developed in order to inhibit the hydrodechlorination in the selective hydrogenation of chloronitrobenzenes to chloroanilines which are important intermediates in the chemistry and industry of dyes, herbicides, pesticides and medicines. However, hydrogenolysis of the carbon-halogen bond as a defect of the hydrogenation process could not be avoided completely over the metal catalysts reported previously, especially at complete conversion of the substrates. Recently we overcame this problem by the invention of nanocomposite catalysts composed of noble metal nanoclusters and inorganic semiconductor nanoparticles. Over these nanocomposite catalysts, the hydrodechlorination of ortho-chloroaniline was completely suppressed even at 100% conversion of ortho-chloronitrobenzene. In this review, we deal with the great efforts and remarkable contributions of different authors during the long exploration for the solutions of this hard obstacle. Stress is placed on supported metal catalysts and polymer-protected metal nanoclusters or colloid catalysts.
Export Options
About this article
Cite this article as:
Wang Xiaodong, Liang Minghui, Zhang Junling and Wang Yuan, Selective Hydrogenation of Aromatic Chloronitro Compounds, Current Organic Chemistry 2007; 11 (3) . https://dx.doi.org/10.2174/138527207779940856
DOI https://dx.doi.org/10.2174/138527207779940856 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunological Disturbances and Neuroimaging Findings in Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD) Comorbid Patients
Current Topics in Medicinal Chemistry Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors
Current Topics in Medicinal Chemistry Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?
Coronaviruses Synthesis and Evaluation of Novel Diazaspiro Hydantoins as Potential Anticonvulsants
Central Nervous System Agents in Medicinal Chemistry Extrasynaptic GABA and Glutamate Receptors in Epilepsy
CNS & Neurological Disorders - Drug Targets The Role of Transcription Factor Pitx3 in Dopamine Neuron Development and Parkinsons Disease
Current Topics in Medicinal Chemistry Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics
Recent Patents on CNS Drug Discovery (Discontinued) Five Markers Capable to Identify Passive Smoking Exposure Associated with Endothelial Dysfunction in Healthy Individuals
Current Hypertension Reviews Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders
Recent Patents on CNS Drug Discovery (Discontinued) The Psychopharmacology of Appetite: Targets for Potential Anti-Obesity Agents
Current Medicinal Chemistry - Central Nervous System Agents Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
Current Neuropharmacology Mesenchymal Stem Cells for Multiple Sclerosis: Does Neural Differentiation Really Matter?
Current Stem Cell Research & Therapy The Implicit Power Motive and Adolescents` Salivary Cortisol Responses to Acute Psychosocial Stress and Exercise in School
CNS & Neurological Disorders - Drug Targets Moraceae Plants with Tyrosinase Inhibitory Activity: A Review
Mini-Reviews in Medicinal Chemistry Iron Overload and Glucose Metabolism in Subjects with β-thalassaemia Major : An Overview
Current Diabetes Reviews Atypical antipsychotics and inverse agonism at 5-HT<sub>2</sub> receptors
Current Pharmaceutical Design Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules
Current Pharmaceutical Design Cyclobutane Biomolecules: Synthetic Approaches to Amino Acids, Peptides and Nucleosides
Current Organic Chemistry Beyond the Cardiac Myofilament: Hypertrophic Cardiomyopathy- Associated Mutations in Genes that Encode Calcium-Handling Proteins
Current Molecular Medicine Genetic Susceptibility to Autoimmune Disorders: Clues from Gene Association and Gene Expression Studies
Current Molecular Medicine